Advertisement
Advertisement

IFRX

IFRX logo

InflaRx N.V. Common Stock

2.58
USD
Sponsored
-0.07
-2.64%
May 08, 16:00 UTC -4
Closed
exchange

After-Market

2.60

+0.02
+0.58%

InflaRx N.V. Common Stock Profile

About

InflaRx N.V. is a clinical-stage biopharmaceutical company. It focused on applying its proprietary anti-C5a technology to discover and develop first-in-class, potent and specific inhibitors of C5a. InflaRx N.V. is based in Germany.

Info & Links

CEO

Niels Riedemann

Headquarters

WINZERLAER STR. 2
JENA, 2M 07745, GERMANY

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.inflarx.de

Auditor

KPMG AG Wirtschaftspr�fungsgesellschaft

Share holders

--

Employees

65

InflaRx N.V. Common Stock Statistics

Valuation Measures

Market Capitalization2

187.60M

Enterprise Value

170.05M

Enterprise Value/EBITDA(ttm)

-3.29

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

1.58

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

2032.88%

Operating Margin(ttm)

--

Profit Margin(ttm)

-14284.95%

Return on Equity(ttm)

-80.51%

Return on Invested Capital(ttm)

-89.99%

Return on Assets(ttm)

-61.36%

Income Statement

Revenue(ttm)

33.30K

Revenue Per Share(ttm)

--

Gross Profit(ttm)

-8.18M

EBITDA(ttm)3

-51.62M

Net Income Available to Common(ttm)

-49.42M

Diluted EPS(ttm)

-0.76

Share Statistics

Beta (5Y Monthly)

1.49

52-Week Change

63.29%

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

--

Dividend Yield

0.00%

Float4

60.51M

% Held by Insiders

16.30%

% Held by Institutions

42.39%

Balance Sheet

Total Cash(mrq)

49.78M

Total Cash Per Share(mrq)

--

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

4.13%

Quick Ratio(mrq)

4.13%

Book Value Per Share(mrq)

0.65

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.59

Free Cash Flow(ytd)

-39.95M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement